Superior metastasis-free survival for patients with high-risk prostate cancer treated with definitive radiation therapy compared to radical prostatectomy: A propensity score-matche...

by Stephanie Markovina, MD, PhD, Marshall W. Meeks, MD, Shahed Badiyan, MD, Joel Vetter, MS, Hiram A. Gay, MD, Alethea Paradis, MTS, Jeff Michalski, MD, MBA, Gurdarshan Sandhu, MD
Published 2018-04-01

Oncological outcomes from trimodality therapy receiving definitive doses of neoadjuvant chemoradiation (≥60 Gy) and factors influencing consideration for surgery in stage III non-s...

by Melissa A.L. Vyfhuis, MD PhD, Neha Bhooshan, MD PhD, Whitney M. Burrows, MD, Michelle Turner, NP, Mohan Suntharalingam, MD MBA, James Donahue, MD, Elizabeth M. Nichols, MD, Josephine Feliciano, MD, Søren M. Bentzen, PhD DMSc, Shahed Badiyan, MD, Shamus R. Carr, MD, Joseph Friedberg, MD, Charles B. Simone, II, MD, Martin J. Edelman, MD, Steven J. Feigenberg, MD, Pranshu Mohindra, MD
Published 2017-07-01